| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| 5-hydroxytryptamine receptor 2C | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 2A | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 1A | 0 | 5 | 2 | 8 |
| 5-hydroxytryptamine receptor 1B | 0 | 3 | 1 | 4 |
| 5-hydroxytryptamine receptor 1D | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 1F | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 6 | 0 | 0 | 1 | 1 |
| Sodium-dependent serotonin transporter | 0 | 2 | 1 | 3 |
| Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 7 | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 5A | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 5B | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 3B | 0 | 0 | 1 | 1 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 4 | 0 | 0 | 4 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 3 | 0 | 0 | 3 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 3 | 0 | 0 | 3 |
| Chain A, Troponin C, slow skeletal and cardiac muscles | 0 | 0 | 1 | 1 |
| Chain A, 2-oxoglutarate Oxygenase | 3 | 0 | 0 | 3 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 2 | 0 | 0 | 2 |
| Chain A, Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 0 | 1 | 1 |
| Chain A, POLYMERASE PA | 0 | 1 | 0 | 1 |
| Chain A, Polymerase Pa | 0 | 1 | 0 | 1 |
| Chain A, Polymerase Pa | 0 | 1 | 0 | 1 |
| Chain A, Polymerase Pa | 0 | 1 | 0 | 1 |
| Chain A, Polymerase Pa | 0 | 1 | 0 | 1 |
| Genome polyprotein | 0 | 1 | 0 | 1 |
| Luciferase | 3 | 0 | 0 | 3 |
| acetylcholinesterase | 2 | 0 | 0 | 2 |
| phosphopantetheinyl transferase | 4 | 0 | 0 | 4 |
| hypoxia-inducible factor 1 alpha subunit | 1 | 0 | 0 | 1 |
| GLI family zinc finger 3 | 4 | 0 | 0 | 4 |
| Microtubule-associated protein tau | 4 | 0 | 0 | 4 |
| AR protein | 4 | 0 | 0 | 4 |
| thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
| nuclear receptor subfamily 1, group I, member 3 | 2 | 0 | 0 | 2 |
| estrogen-related nuclear receptor alpha | 4 | 0 | 0 | 4 |
| estrogen nuclear receptor alpha | 5 | 0 | 0 | 5 |
| bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
| peroxisome proliferator activated receptor gamma | 2 | 0 | 0 | 2 |
| euchromatic histone-lysine N-methyltransferase 2 | 6 | 0 | 0 | 6 |
| thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
| activating transcription factor 6 | 3 | 0 | 0 | 3 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 1 | 0 | 0 | 1 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 3 | 0 | 0 | 3 |
| Histone H2A.x | 3 | 0 | 0 | 3 |
| Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
| lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
| galactokinase | 2 | 0 | 0 | 2 |
| thyroid hormone receptor beta isoform a | 2 | 0 | 0 | 2 |
| thyroid hormone receptor beta isoform 2 | 3 | 0 | 0 | 3 |
| heat shock protein beta-1 | 2 | 0 | 0 | 2 |
| pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
| DNA polymerase beta | 2 | 0 | 0 | 2 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 2 | 0 | 0 | 2 |
| POsterior Segregation | 0 | 0 | 1 | 1 |
| Prostaglandin E synthase | 0 | 1 | 0 | 1 |
| Telomerase reverse transcriptase | 0 | 1 | 0 | 1 |
| Polycomb protein EED | 0 | 0 | 1 | 1 |
| Bile salt export pump | 0 | 3 | 0 | 3 |
| NAD kinase | 0 | 2 | 1 | 3 |
| Dihydrofolate reductase | 0 | 0 | 0 | 1 |
| Urokinase-type plasminogen activator | 0 | 3 | 0 | 3 |
| Tissue-type plasminogen activator | 0 | 2 | 0 | 2 |
| Transthyretin | 0 | 0 | 1 | 1 |
| Polymerase acidic protein | 0 | 1 | 0 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 2 | 0 | 2 |
| Cellular tumor antigen p53 | 3 | 0 | 0 | 3 |
| Amyloid-beta precursor protein | 0 | 3 | 0 | 3 |
| Plasminogen activator inhibitor 1 | 0 | 2 | 0 | 2 |
| Heme oxygenase 1 | 0 | 1 | 0 | 1 |
| Urokinase-type plasminogen activator | 0 | 2 | 0 | 2 |
| ATP-dependent translocase ABCB1 | 0 | 4 | 1 | 5 |
| Heat shock protein HSP 90-beta | 0 | 1 | 0 | 1 |
| Neutrophil elastase | 0 | 3 | 0 | 3 |
| 72 kDa type IV collagenase | 0 | 3 | 0 | 3 |
| Hepatocyte growth factor receptor | 0 | 3 | 0 | 3 |
| Matrilysin | 0 | 2 | 0 | 2 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 0 | 2 | 0 | 2 |
| Replicase polyprotein 1ab | 0 | 3 | 1 | 4 |
| Alpha-amylase 1A | 0 | 2 | 0 | 2 |
| Apoptosis regulator Bcl-2 | 0 | 2 | 0 | 2 |
| Microtubule-associated protein tau | 0 | 1 | 0 | 1 |
| 60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
| Fatty acid synthase | 0 | 1 | 0 | 1 |
| CPG DNA methylase | 0 | 1 | 0 | 1 |
| Lethal factor | 0 | 1 | 0 | 1 |
| Phosphoglycerate mutase 1 | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
| Heme oxygenase 2 | 0 | 1 | 0 | 1 |
| Sodium-dependent noradrenaline transporter | 0 | 0 | 1 | 1 |
| Adenosine receptor A1 | 1 | 2 | 0 | 3 |
| DNA (cytosine-5)-methyltransferase 1 | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 4 | 0 | 3 | 0 | 3 |
| Proteasome subunit beta type-5 | 0 | 3 | 0 | 3 |
| Cannabinoid receptor 2 | 0 | 1 | 0 | 1 |
| Signal transducer and activator of transcription 1-alpha/beta | 0 | 0 | 1 | 1 |
| DNA repair protein RAD52 homolog | 0 | 1 | 0 | 1 |
| Fatty acid synthase | 0 | 1 | 0 | 1 |
| Matrix metalloproteinase-14 | 0 | 1 | 0 | 1 |
| 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 | 0 | 2 | 0 | 2 |
| Squalene monooxygenase | 0 | 2 | 0 | 2 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
| BH3-interacting domain death agonist | 0 | 1 | 0 | 1 |
| Beta-secretase 1 | 0 | 3 | 0 | 3 |
| 10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 2 | 0 | 3 |
| Lactoperoxidase | 0 | 1 | 0 | 3 |
| Bcl-2-like protein 1 | 0 | 1 | 0 | 1 |
| Induced myeloid leukemia cell differentiation protein Mcl-1 | 0 | 1 | 0 | 1 |
| Histone acetyltransferase p300 | 0 | 1 | 0 | 1 |
| Alpha-(1,3)-fucosyltransferase 7 | 0 | 2 | 0 | 2 |
| CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 | 0 | 2 | 0 | 2 |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 1 | 0 | 1 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 14 | 0 | 2 | 0 | 2 |
| Bcl-2-related protein A1 | 0 | 1 | 0 | 1 |
| Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 1 | 0 | 1 |
| Reverse transcriptase/RNaseH | 0 | 2 | 0 | 2 |
| 10 kDa chaperonin | 0 | 1 | 0 | 1 |
| 3-oxoacyl-[acyl-carrier-protein] reductase | 0 | 1 | 0 | 1 |
| MAP kinase-activated protein kinase 5 | 0 | 1 | 0 | 1 |
| CREB-binding protein | 0 | 1 | 0 | 1 |
| Histone acetyltransferase KAT2B | 0 | 1 | 0 | 1 |
| Bcl-2-like protein 2 | 0 | 1 | 0 | 1 |
| Bcl2-associated agonist of cell death | 0 | 1 | 0 | 1 |
| Histone acetyltransferase KAT5 | 0 | 1 | 0 | 1 |
| Enoyl-acyl-carrier protein reductase | 0 | 4 | 0 | 4 |
| 3-oxoacyl-acyl-carrier protein reductase | 0 | 2 | 0 | 2 |
| Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein) | 0 | 2 | 0 | 2 |
| Bcl-2-like protein 10 | 0 | 1 | 0 | 1 |
| Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
| Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
| Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
| interleukin 8 | 1 | 0 | 0 | 1 |
| RAR-related orphan receptor gamma | 2 | 0 | 0 | 2 |
| GLS protein | 3 | 0 | 0 | 3 |
| TDP1 protein | 4 | 0 | 0 | 4 |
| aldehyde dehydrogenase 1 family, member A1 | 2 | 0 | 0 | 2 |
| hypothetical protein, conserved | 1 | 0 | 0 | 1 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 1 | 0 | 0 | 1 |
| glucocorticoid receptor [Homo sapiens] | 2 | 0 | 0 | 2 |
| retinoic acid nuclear receptor alpha variant 1 | 3 | 0 | 0 | 3 |
| farnesoid X nuclear receptor | 1 | 0 | 0 | 1 |
| 67.9K protein | 2 | 0 | 0 | 2 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 2 | 0 | 0 | 2 |
| cellular tumor antigen p53 isoform a | 2 | 0 | 0 | 2 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 3 | 0 | 0 | 3 |
| vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
| fructose-bisphosphate aldolase A | 1 | 0 | 0 | 1 |
| glyceraldehyde-3-phosphate dehydrogenase isoform 1 | 1 | 0 | 0 | 1 |
| mitogen-activated protein kinase 1 | 2 | 0 | 0 | 2 |
| nuclear receptor ROR-gamma isoform 1 | 1 | 0 | 0 | 1 |
| DNA polymerase kappa isoform 1 | 4 | 0 | 0 | 4 |
| survival motor neuron protein isoform d | 2 | 0 | 0 | 2 |
| histone acetyltransferase KAT2A isoform 1 | 1 | 0 | 0 | 1 |
| lethal factor (plasmid) | 1 | 0 | 0 | 1 |
| lamin isoform A-delta10 | 2 | 0 | 0 | 2 |
| Carbonic anhydrase 12 | 0 | 2 | 0 | 2 |
| Voltage-dependent calcium channel gamma-2 subunit | 1 | 0 | 0 | 1 |
| Pancreatic triacylglycerol lipase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 1 | 0 | 2 | 0 | 3 |
| Carbonic anhydrase 2 | 0 | 2 | 0 | 3 |
| Integrin beta-3 | 2 | 0 | 1 | 3 |
| Carbonic anhydrase 3 | 0 | 2 | 0 | 2 |
| Integrin alpha-IIb | 2 | 0 | 1 | 3 |
| Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
| L-selectin | 0 | 1 | 0 | 1 |
| P-selectin | 0 | 1 | 0 | 1 |
| E-selectin | 0 | 1 | 0 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 1 | 0 | 1 |
| Glutamate receptor 2 | 1 | 2 | 1 | 4 |
| Carbonic anhydrase 4 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 6 | 0 | 2 | 0 | 2 |
| Nitric oxide synthase, inducible | 0 | 2 | 0 | 2 |
| Adenosine receptor A2a | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 2 | 0 | 2 |
| Alpha-synuclein | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 7 | 0 | 2 | 0 | 2 |
| Autoinducer 2-binding periplasmic protein LuxP | 0 | 1 | 0 | 1 |
| Anthrax toxin receptor 2 | 0 | 2 | 0 | 2 |
| Polypeptide N-acetylgalactosaminyltransferase 2 | 0 | 1 | 1 | 2 |
| Carbonic anhydrase 9 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 2 | 0 | 2 |
| Toll-like receptor 2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 2 | 0 | 2 |
| ATP-dependent phosphofructokinase | 2 | 0 | 0 | 2 |
| Chain A, GLUTAMATE RECEPTOR SUBUNIT 2 | 0 | 1 | 0 | 1 |
| Chain A, Glutamate Receptor Subunit 2 | 0 | 1 | 0 | 1 |
| Chain B, Glutamate Receptor Subunit 2 | 0 | 1 | 0 | 1 |
| Chain A, Slr1257 protein | 0 | 0 | 1 | 1 |
| Chain A, Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] | 0 | 1 | 0 | 1 |
| glp-1 receptor, partial | 1 | 0 | 0 | 1 |
| thioredoxin reductase | 3 | 0 | 0 | 3 |
| regulator of G-protein signaling 4 | 2 | 0 | 0 | 2 |
| beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
| Metabotropic glutamate receptor 8 | 0 | 2 | 0 | 2 |
| Metabotropic glutamate receptor 6 | 0 | 1 | 1 | 3 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
| Excitatory amino acid transporter 4 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
| Glutathione reductase, mitochondrial | 0 | 3 | 0 | 3 |
| Bifunctional aspartokinase/homoserine dehydrogenase 1 | 0 | 1 | 0 | 1 |
| Prothrombin | 0 | 1 | 2 | 3 |
| ATP-citrate synthase | 0 | 1 | 0 | 1 |
| Glutamate receptor 1 | 0 | 2 | 1 | 3 |
| Glutamate receptor 3 | 0 | 2 | 1 | 3 |
| Glutamate receptor 4 | 0 | 2 | 1 | 3 |
| Glutamate receptor ionotropic, kainate 1 | 0 | 2 | 1 | 3 |
| Metabotropic glutamate receptor 1 | 0 | 1 | 1 | 2 |
| Metabotropic glutamate receptor 2 | 0 | 0 | 1 | 1 |
| Metabotropic glutamate receptor 3 | 0 | 0 | 1 | 1 |
| Metabotropic glutamate receptor 4 | 0 | 1 | 1 | 2 |
| Metabotropic glutamate receptor 5 | 0 | 0 | 1 | 1 |
| Metabotropic glutamate receptor 6 | 0 | 0 | 1 | 1 |
| Metabotropic glutamate receptor 7 | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 1 | 3 |
| Glutamate receptor ionotropic, kainate 1 | 0 | 1 | 1 | 2 |
| Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 3 |
| Glutamate receptor ionotropic, kainate 2 | 0 | 2 | 1 | 3 |
| Glutamate receptor 1 | 0 | 2 | 1 | 3 |
| Glutamate receptor 2 | 0 | 2 | 1 | 3 |
| Glutamate receptor 3 | 0 | 1 | 1 | 2 |
| Glutamate receptor ionotropic, kainate 3 | 0 | 2 | 0 | 2 |
| Excitatory amino acid transporter 1 | 0 | 2 | 0 | 3 |
| Excitatory amino acid transporter 2 | 0 | 2 | 0 | 3 |
| Excitatory amino acid transporter 3 | 0 | 2 | 0 | 3 |
| Metabotropic glutamate receptor 8 | 0 | 0 | 1 | 1 |
| Glutamate receptor 4 | 0 | 2 | 1 | 3 |
| Excitatory amino acid transporter 3 | 0 | 0 | 0 | 1 |
| Glutamate racemase | 0 | 0 | 0 | 1 |
| Metabotropic glutamate receptor 8 | 0 | 1 | 1 | 2 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 1 | 3 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 1 | 3 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 1 | 3 |
| Glutamate receptor ionotropic, kainate 4 | 0 | 2 | 0 | 2 |
| Glutamate carboxypeptidase 2 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, kainate 2 | 0 | 1 | 1 | 2 |
| Glutamate receptor ionotropic, kainate 3 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
| Metabotropic glutamate receptor 1 | 0 | 1 | 1 | 3 |
| Metabotropic glutamate receptor 2 | 0 | 1 | 1 | 3 |
| Metabotropic glutamate receptor 7 | 0 | 1 | 1 | 3 |
| Metabotropic glutamate receptor 3 | 0 | 1 | 1 | 3 |
| Metabotropic glutamate receptor 4 | 0 | 1 | 1 | 3 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, kainate 5 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 1 | 3 |
| Glutamate receptor ionotropic, kainate 5 | 0 | 2 | 0 | 2 |
| Glutamate racemase | 0 | 0 | 0 | 1 |
| Prolyl 4-hydroxylase | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 1 | 3 |
| Alpha-ketoglutarate-dependent dioxygenase FTO | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 1 | 3 |
| Chain A, 3-phosphoshikimate 1-carboxyvinyltransferase | 0 | 1 | 0 | 1 |
| Chain A, 3-phosphoshikimate 1-carboxyvinyltransferase | 0 | 1 | 0 | 1 |
| Glutamine synthetase | 0 | 1 | 0 | 1 |
| Cytochrome P450 71B1 | 0 | 1 | 0 | 2 |
| Glutamine synthetase | 0 | 1 | 0 | 1 |
| 2-dehydro-3-deoxyphosphooctonate aldolase | 0 | 1 | 0 | 1 |
| Beta-1 adrenergic receptor | 0 | 1 | 1 | 3 |
| arylsulfatase A | 2 | 0 | 0 | 2 |
| D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit pi | 1 | 1 | 1 | 3 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 3 | 0 | 2 | 0 | 2 |
| Multidrug resistance-associated protein 4 | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Bile salt export pump | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
| Albumin | 0 | 0 | 1 | 1 |
| Cytochrome P450 1A2 | 0 | 2 | 0 | 2 |
| Beta-2 adrenergic receptor | 0 | 2 | 1 | 3 |
| Muscarinic acetylcholine receptor M2 | 0 | 1 | 1 | 2 |
| Beta-1 adrenergic receptor | 0 | 2 | 1 | 3 |
| Cytochrome P450 3A4 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 1 | 2 |
| Alpha-2A adrenergic receptor | 0 | 1 | 2 | 4 |
| Adenosine receptor A3 | 0 | 2 | 1 | 3 |
| Beta-2 adrenergic receptor | 0 | 2 | 0 | 3 |
| Cytochrome P450 2C8 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2D6 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M1 | 0 | 1 | 1 | 2 |
| Cytochrome P450 2C9 | 0 | 2 | 0 | 2 |
| Beta-3 adrenergic receptor | 0 | 2 | 1 | 3 |
| D(2) dopamine receptor | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 1 | 1 | 1 | 3 |
| Alpha-1B adrenergic receptor | 0 | 2 | 1 | 3 |
| Alpha-2B adrenergic receptor | 0 | 0 | 1 | 2 |
| Beta-1 adrenergic receptor | 0 | 2 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit delta | 1 | 1 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 1 | 1 | 1 | 3 |
| Alpha-2C adrenergic receptor | 0 | 1 | 2 | 4 |
| D(3) dopamine receptor | 0 | 2 | 0 | 2 |
| Alpha-2B adrenergic receptor | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 1 | 1 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 1 | 1 | 1 | 3 |
| Muscarinic acetylcholine receptor M3 | 0 | 1 | 1 | 2 |
| D(1A) dopamine receptor | 0 | 1 | 1 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 0 | 1 | 1 |
| Alpha-2A adrenergic receptor | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 1 | 1 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 1 | 1 | 1 | 3 |
| Alpha-1D adrenergic receptor | 0 | 1 | 1 | 2 |
| Alpha-1D adrenergic receptor | 0 | 0 | 1 | 2 |
| Endothelin-1 receptor | 0 | 1 | 1 | 2 |
| Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1B | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 2A | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 1 | 1 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 1 | 1 | 1 | 3 |
| Adenosine receptor A2a | 0 | 1 | 1 | 2 |
| Neuromedin-K receptor | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 1 | 1 | 1 | 3 |
| Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
| Cholecystokinin receptor type A | 0 | 1 | 1 | 2 |
| Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 1 | 2 |
| Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 1 | 2 | 4 |
| Alpha-1B adrenergic receptor | 0 | 0 | 1 | 2 |
| Mu-type opioid receptor | 0 | 1 | 1 | 2 |
| Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
| Delta-type opioid receptor | 0 | 1 | 1 | 2 |
| Kappa-type opioid receptor | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 2 | 1 | 3 |
| Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 6 | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 1 | 1 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 1 | 1 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 1 | 1 | 1 | 3 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 1 | 1 | 3 |
| GABA theta subunit | 1 | 1 | 1 | 3 |
| Canalicular multispecific organic anion transporter 1 | 0 | 2 | 0 | 2 |
| Ataxin-2 | 1 | 0 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit epsilon | 1 | 1 | 1 | 3 |
| Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 2 | 2 |
| Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
| Chain A, Cruzipain | 2 | 0 | 0 | 2 |
| Chain A, APH(2')-Id | 0 | 1 | 0 | 1 |
| glucose-6-phosphate dehydrogenase | 0 | 1 | 0 | 1 |
| Nrf2 | 1 | 0 | 0 | 1 |
| 15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
| SMAD family member 2 | 1 | 0 | 0 | 1 |
| ATAD5 protein, partial | 1 | 0 | 0 | 1 |
| USP1 protein, partial | 1 | 0 | 0 | 1 |
| NFKB1 protein, partial | 1 | 0 | 0 | 1 |
| SMAD family member 3 | 1 | 0 | 0 | 1 |
| signal transducer and activator of transcription 6, interleukin-4 induced | 1 | 0 | 0 | 1 |
| Smad3 | 1 | 0 | 0 | 1 |
| DNA polymerase III, partial | 1 | 0 | 0 | 1 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
| thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
| estrogen receptor 2 (ER beta) | 1 | 0 | 0 | 1 |
| progesterone receptor | 1 | 0 | 0 | 1 |
| EWS/FLI fusion protein | 1 | 0 | 0 | 1 |
| retinoid X nuclear receptor alpha | 1 | 0 | 0 | 1 |
| pregnane X nuclear receptor | 1 | 0 | 0 | 1 |
| Neuraminidase | 0 | 2 | 0 | 2 |
| glucocerebrosidase | 1 | 0 | 0 | 1 |
| Parkin | 1 | 0 | 0 | 1 |
| peroxisome proliferator-activated receptor delta | 1 | 0 | 0 | 1 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
| aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
| hexokinase | 0 | 1 | 0 | 1 |
| Spike glycoprotein | 0 | 0 | 1 | 1 |
| Bloom syndrome protein isoform 1 | 1 | 0 | 0 | 1 |
| cytochrome P450 2D6 isoform 1 | 1 | 0 | 0 | 1 |
| peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
| interferon gamma precursor | 0 | 0 | 0 | 1 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
| cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
| cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
| chromobox protein homolog 1 | 1 | 0 | 0 | 1 |
| histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
| flap endonuclease 1 | 1 | 0 | 0 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
| tyrosine-protein kinase Yes | 1 | 0 | 0 | 1 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
| DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
| DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
| cytochrome P450 3A4 isoform 1 | 1 | 0 | 0 | 1 |
| M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
| muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
| muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
| neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 1 | 0 | 2 |
| Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
| Polyphenol oxidase 2 | 0 | 1 | 0 | 2 |
| Maltase-glucoamylase, intestinal | 0 | 1 | 0 | 1 |
| NUAK family SNF1-like kinase 1 | 0 | 1 | 0 | 1 |
| Lysine-specific histone demethylase 1A | 0 | 1 | 0 | 1 |
| B2 bradykinin receptor | 0 | 1 | 0 | 1 |
| G2/mitotic-specific cyclin-B2 | 0 | 1 | 0 | 1 |
| Arginase | 0 | 1 | 0 | 1 |
| Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
| Prothrombin | 0 | 1 | 0 | 1 |
| Cationic trypsin | 0 | 1 | 0 | 1 |
| Chymotrypsinogen A | 0 | 1 | 0 | 1 |
| Chymotrypsin-like elastase family member 1 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Protein E6 | 0 | 1 | 0 | 1 |
| Neuraminidase | 0 | 1 | 0 | 1 |
| Interstitial collagenase | 0 | 1 | 1 | 2 |
| Phospholipase A2 | 0 | 1 | 0 | 1 |
| Cytochrome P450 1A1 | 0 | 2 | 1 | 3 |
| Myeloperoxidase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
| Glycogen phosphorylase, liver form | 0 | 1 | 0 | 1 |
| Epoxide hydrolase 1 | 0 | 1 | 0 | 1 |
| Trypsin-1 | 0 | 1 | 0 | 1 |
| Trypsin-2 | 0 | 1 | 0 | 1 |
| Procathepsin L | 0 | 0 | 1 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Yes | 0 | 1 | 0 | 1 |
| Proto-oncogene tyrosine-protein kinase receptor Ret | 0 | 1 | 0 | 1 |
| Insulin-like growth factor 1 receptor | 0 | 1 | 0 | 1 |
| Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 3 |
| Stromelysin-1 | 0 | 1 | 0 | 1 |
| Heterogeneous nuclear ribonucleoprotein A1 | 0 | 0 | 1 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1a | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 2 | 1 | 3 |
| Calmodulin-1 | 0 | 1 | 0 | 1 |
| Lysosomal alpha-glucosidase | 0 | 1 | 0 | 1 |
| Sialidase | 0 | 1 | 0 | 1 |
| Malate dehydrogenase | 0 | 1 | 0 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 2 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase pim-1 | 0 | 1 | 1 | 2 |
| Aromatase | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 4 | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
| Proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
| Cystic fibrosis transmembrane conductance regulator | 0 | 0 | 1 | 1 |
| Sucrase-isomaltase, intestinal | 0 | 1 | 0 | 1 |
| G2/mitotic-specific cyclin-B1 | 0 | 1 | 0 | 1 |
| Tyrosinase | 0 | 1 | 0 | 1 |
| Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
| Urease subunit alpha | 0 | 3 | 0 | 3 |
| Serine/threonine-protein kinase B-raf | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| G2/mitotic-specific cyclin-B | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Chymotrypsinogen B | 0 | 1 | 0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX12 | 0 | 1 | 0 | 1 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 4 | 0 | 1 | 0 | 1 |
| Casein kinase II subunit alpha' | 0 | 2 | 0 | 2 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| 5'-nucleotidase | 0 | 1 | 0 | 1 |
| D(4) dopamine receptor | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Glyceraldehyde-3-phosphate dehydrogenase, glycosomal | 0 | 1 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
| G1/S-specific cyclin-D1 | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 2 | 0 | 1 | 0 | 1 |
| C-X-C chemokine receptor type 1 | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 3-kinase regulatory subunit alpha | 0 | 1 | 0 | 1 |
| Cytosol aminopeptidase | 0 | 1 | 0 | 1 |
| ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 | 0 | 1 | 0 | 1 |
| Vasopressin V2 receptor | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase receptor UFO | 0 | 1 | 0 | 1 |
| Substance-P receptor | 0 | 2 | 0 | 2 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| RAC-alpha serine/threonine-protein kinase | 0 | 1 | 0 | 1 |
| Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
| Bifunctional epoxide hydrolase 2 | 0 | 1 | 0 | 1 |
| Trypsin-3 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Vascular endothelial growth factor receptor 2 | 0 | 1 | 0 | 1 |
| Receptor-type tyrosine-protein kinase FLT3 | 0 | 1 | 0 | 1 |
| 17-beta-hydroxysteroid dehydrogenase type 2 | 0 | 1 | 0 | 1 |
| Macrophage metalloelastase | 0 | 1 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
| Glutathione reductase | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase SYK | 0 | 1 | 1 | 2 |
| Collagenase 3 | 0 | 1 | 0 | 1 |
| 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 1 | 0 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 2 | 0 | 2 |
| Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
| Prolyl endopeptidase | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 1 |
| Glycogen synthase kinase-3 alpha | 0 | 1 | 0 | 1 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| C-C chemokine receptor type 4 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase Nek2 | 0 | 1 | 0 | 1 |
| Oligo-1,6-glucosidase IMA1 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase PLK1 | 0 | 1 | 0 | 1 |
| Death-associated protein kinase 1 | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 10 | 0 | 1 | 0 | 1 |
| Monocarboxylate transporter 1 | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| Spike glycoprotein | 0 | 0 | 1 | 1 |
| Casein kinase II subunit beta | 0 | 2 | 0 | 2 |
| Casein kinase II subunit alpha | 0 | 2 | 0 | 2 |
| Urease subunit beta | 0 | 3 | 0 | 3 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 2 | 0 | 3 |
| Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
| Cyclin-dependent kinase 6 | 0 | 1 | 0 | 1 |
| Cyclin-dependent-like kinase 5 | 0 | 1 | 0 | 1 |
| Heat shock factor protein 1 | 0 | 1 | 0 | 1 |
| Sorbitol dehydrogenase | 0 | 1 | 0 | 1 |
| Cyclin homolog | 0 | 1 | 0 | 1 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 1 | 0 | 1 | 0 | 1 |
| Lactoylglutathione lyase | 0 | 2 | 0 | 2 |
| Focal adhesion kinase 1 | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit beta | 0 | 1 | 0 | 1 |
| ELAV-like protein 3 | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 5 activator 1 | 0 | 1 | 0 | 1 |
| ELAV-like protein 1 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase N1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 1B1 | 0 | 2 | 1 | 3 |
| Probable maltase-glucoamylase 2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
| Monocarboxylate transporter 2 | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Substance-K receptor | 0 | 1 | 0 | 1 |
| Integrase | 0 | 1 | 0 | 1 |
| Casein kinase II subunit alpha 3 | 0 | 2 | 0 | 2 |
| Inositol polyphosphate multikinase | 0 | 1 | 0 | 1 |
| G2/mitotic-specific cyclin-B3 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C21 | 0 | 2 | 0 | 2 |
| Aurora kinase B | 0 | 1 | 0 | 1 |
| Chymotrypsin-C | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme 2 | 0 | 0 | 1 | 1 |
| Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
| Phosphodiesterase | 0 | 1 | 0 | 1 |
| G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
| Serine/threonine-protein kinase Nek6 | 0 | 1 | 0 | 1 |
| NADPH oxidase 4 | 0 | 1 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha inhibitor | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 3 | 0 | 1 | 0 | 1 |
| Inositol hexakisphosphate kinase 2 | 0 | 1 | 0 | 1 |
| Short transient receptor potential channel 5 | 0 | 1 | 0 | 1 |
| ALK tyrosine kinase receptor | 0 | 1 | 0 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 1 | 2 |
| Sialidase-2 | 0 | 1 | 0 | 1 |
| phosphoglycerate kinase | 1 | 0 | 0 | 1 |
| Substance-P receptor | 0 | 2 | 0 | 2 |
| Neuromedin-K receptor | 0 | 0 | 1 | 1 |
| Substance-K receptor | 0 | 1 | 1 | 2 |
| Substance-K receptor | 0 | 2 | 0 | 2 |
| Substance-P receptor | 0 | 2 | 1 | 3 |
| Neuromedin-K receptor | 0 | 1 | 1 | 2 |
| Substance-K receptor | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 0 | 1 | 1 |
| Substance-K receptor | 0 | 1 | 0 | 1 |
| Growth hormone secretagogue receptor type 1 | 0 | 0 | 1 | 1 |
| Mas-related G-protein coupled receptor member X2 | 0 | 0 | 1 | 1 |
| isocitrate dehydrogenase 1, partial | 1 | 0 | 0 | 1 |
| serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
| Alcohol dehydrogenase E chain | 0 | 1 | 0 | 1 |
| Alcohol dehydrogenase S chain | 0 | 1 | 0 | 1 |
| Urease | 0 | 2 | 0 | 3 |
| Urease subunit alpha | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-gamma | 1 | 0 | 0 | 1 |
| Urease subunit beta | 0 | 1 | 0 | 1 |
| Serine-protein kinase ATM | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase ATR | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |